Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Tw, Pearson"'
Autor:
TW Pearson, AM Goldner
Publikováno v:
The American journal of physiology. 225(6)
Autor:
TW Pearson, AM Goldner
Publikováno v:
The American journal of physiology. 227(2)
Publikováno v:
Europe PubMed Central
Procyclic culture form (PCF) trypanosomes were established from a bloodstream form population of cloned Trypanosoma brucei rhodesiense and were used to immunize mice for hybridoma production. Indirect immunofluorescence was used to select 10 hybridom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::170054704173007a0eba057bc6880e7c
http://europepmc.org/abstract/med/3512712
http://europepmc.org/abstract/med/3512712
Publikováno v:
Europe PubMed Central
Apoptosis is a phenomenon previously associated exclusively with metazoan organisms. We show here that procyclic insect form Trypanosoma brucei rhodesiense, a protozoan parasite, when treated in vitro with concanavalin A displayed several features no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::156125ae5c84fd66c9b4a8968c4fba1e
http://europepmc.org/abstract/med/17180087
http://europepmc.org/abstract/med/17180087
Autor:
Lane D; The Department of Chemical Pathology and Metabolic Diseases, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., Allsopp R; Department of Genetics and Genome Biology, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Holmes CW; Clinical Microbiology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK., Slingsby OC; van Geest MS-OMICS Facility, University of Leicester, Leicester, UK., Jukes-Jones R; The Department of Chemical Pathology and Metabolic Diseases, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK., Bird P; Clinical Microbiology, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK., Anderson NL; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Razavi M; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Yip R; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Pearson TW; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Pope M; SISCAPA Assay Technologies, Inc., Washington, DC, USA., Khunti K; Leicester Diabetes Centre, Leicester General Hospital, University of Leicester, Leicester, UK., Doykov I; Genetics & Genomic Medicine Department, Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.; Great Ormond Street Biomedical Research Centre, UCL Institute of Child Health, London, UK., Hällqvist J; Genetics & Genomic Medicine Department, Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.; Great Ormond Street Biomedical Research Centre, UCL Institute of Child Health, London, UK., Mills K; Genetics & Genomic Medicine Department, Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.; Great Ormond Street Biomedical Research Centre, UCL Institute of Child Health, London, UK., Skipp P; Centre for Proteomic Research, University of Southampton, Southampton, UK., Carling R; Biochemical Sciences, Synnovis, Guys & St Thomas' NHSFT, London, UK.; GKT School Medical Education, Kings College London, London, UK., Ng L; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.; van Geest MS-OMICS Facility, University of Leicester, Leicester, UK., Shaw J; Department of Genetics and Genome Biology, Leicester Cancer Research Centre, University of Leicester, Leicester, UK., Gupta P; The Department of Chemical Pathology and Metabolic Diseases, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., Jones DJL; Department of Genetics and Genome Biology, Leicester Cancer Research Centre, University of Leicester, Leicester, UK.; van Geest MS-OMICS Facility, University of Leicester, Leicester, UK.
Publikováno v:
Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2024 Jan 23; Vol. 62 (6), pp. 1206-1216. Date of Electronic Publication: 2024 Jan 23 (Print Publication: 2024).
Autor:
Hober A; Science for Life Laboratory, Solna, Sweden., Tran-Minh KH; Science for Life Laboratory, Solna, Sweden.; The Royal Institute of Technology, Division of Systems Biology, Department of Protein Science, School of Chemistry, Biotechnology and Health, Stockholm, Sweden., Foley D; Waters Corporation, Milford, United Kingdom., McDonald T; Waters Corporation, Milford, United Kingdom., Vissers JP; Waters Corporation, Milford, United Kingdom., Pattison R; Waters Corporation, Milford, United Kingdom., Ferries S; Waters Corporation, Milford, United Kingdom., Hermansson S; Waters Corporation, Milford, United Kingdom., Betner I; Waters Corporation, Milford, United Kingdom., Uhlén M; Science for Life Laboratory, Solna, Sweden.; The Royal Institute of Technology, Division of Systems Biology, Department of Protein Science, School of Chemistry, Biotechnology and Health, Stockholm, Sweden., Razavi M; SISCAPA Assay Technologies, Inc, Victoria, Canada., Yip R; SISCAPA Assay Technologies, Inc, Victoria, Canada., Pope ME; SISCAPA Assay Technologies, Inc, Victoria, Canada., Pearson TW; SISCAPA Assay Technologies, Inc, Victoria, Canada., Andersson LN; SISCAPA Assay Technologies, Inc, Victoria, Canada., Bartlett A; Waters Corporation, Milford, United Kingdom., Calton L; Waters Corporation, Milford, United Kingdom., Alm JJ; Karolinska Institutet, Department of Microbiology, Tumor and Cell Biology & National Pandemic Center, Karolinska Institutet, Solna, Sweden., Engstrand L; Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden., Edfors F; Science for Life Laboratory, Solna, Sweden.; The Royal Institute of Technology, Division of Systems Biology, Department of Protein Science, School of Chemistry, Biotechnology and Health, Stockholm, Sweden.
Publikováno v:
ELife [Elife] 2021 Nov 08; Vol. 10. Date of Electronic Publication: 2021 Nov 08.
Autor:
Anderson L; SISCAPA Assay Technologies, Inc. PO Box 53309, DC 20009, USA., Razavi M; SISCAPA Assay Technologies, Inc. PO Box 53309, DC 20009, USA., Pope ME; SISCAPA Assay Technologies, Inc. PO Box 53309, DC 20009, USA., Yip R; SISCAPA Assay Technologies, Inc. PO Box 53309, DC 20009, USA., Cameron LC; Laboratory of Protein Biochemistry: Federal University of State of Rio de Janeiro. CEP: 22290-255, Rio de Janeiro/RJ, Brazil., Bassini-Cameron A; Laboratory of Protein Biochemistry: Federal University of State of Rio de Janeiro. CEP: 22290-255, Rio de Janeiro/RJ, Brazil., Pearson TW; SISCAPA Assay Technologies, Inc. PO Box 53309, DC 20009, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2020 Jul; Vol. 12 (13), pp. 937-955. Date of Electronic Publication: 2020 Apr 07.
Autor:
Razavi M; SISCAPA Assay Technologies, Inc. Washington, DC mrazavi@siscapa.com., Farrokhi V; Biomedicine Design, Worldwide Research & Development, Pfizer Inc. Andover, MA., Yip R; SISCAPA Assay Technologies, Inc. Washington, DC., Anderson NL; SISCAPA Assay Technologies, Inc. Washington, DC., Pearson TW; SISCAPA Assay Technologies, Inc. Washington, DC., Neubert H; Biomedicine Design, Worldwide Research & Development, Pfizer Inc. Andover, MA.
Publikováno v:
Clinical chemistry [Clin Chem] 2019 Mar; Vol. 65 (3), pp. 492-494. Date of Electronic Publication: 2019 Jan 09.
Autor:
Sucharski FK; Pharmacokinetic Sciences, Novartis Institute for Biomedical Research, CH-4022 Basel, Switzerland., Meier S; Pharmacokinetic Sciences, Novartis Institute for Biomedical Research, CH-4022 Basel, Switzerland.; Amt für Lebensmittelsicherheit und Veterinärwesen, Ressort Chemie Gräubernstrasse 12, CH-4410 Liestal, Switzerland., Miess C; Pharmacokinetic Sciences, Novartis Institute for Biomedical Research, CH-4022 Basel, Switzerland., Razavi M; SISCAPA Assay Technologies, Inc., Washington, DC 20009-3309, USA., Pope M; SISCAPA Assay Technologies, Inc., Washington, DC 20009-3309, USA., Yip R; SISCAPA Assay Technologies, Inc., Washington, DC 20009-3309, USA., Anderson NL; SISCAPA Assay Technologies, Inc., Washington, DC 20009-3309, USA., Pearson TW; SISCAPA Assay Technologies, Inc., Washington, DC 20009-3309, USA., Warren AP; Pharmacokinetic Sciences, Novartis Institute for Biomedical Research, CH-4022 Basel, Switzerland.; Salt River Integrated Bioanalysis GmbH, Bernoullistrasse 20, CH-4056 Basel, Switzerland., Krantz C; Pharmacokinetic Sciences, Novartis Institute for Biomedical Research, CH-4022 Basel, Switzerland.
Publikováno v:
Bioanalysis [Bioanalysis] 2018 Jul 01; Vol. 10 (13), pp. 1023-1037. Date of Electronic Publication: 2018 Jul 04.
Autor:
Topbas C; Cleveland HeartLab, Cleveland, OH., Swick A; Cleveland HeartLab, Cleveland, OH., Razavi M; SISCAPA Assay Technologies, Inc., Washington, DC., Anderson NL; SISCAPA Assay Technologies, Inc., Washington, DC., Pearson TW; SISCAPA Assay Technologies, Inc., Washington, DC., Bystrom C; Cleveland HeartLab, Cleveland, OH; cbystrom@clevelandheartlab.com.
Publikováno v:
Clinical chemistry [Clin Chem] 2018 Apr; Vol. 64 (4), pp. 697-704. Date of Electronic Publication: 2018 Jan 10.